Search

Displaying results 7551 - 7560 of 10000 in total
  1. Drug

    Zurletrectinib

    go.drugbank.com/drugs/DB21601
    Experimental

    The usage of the INN stem '-trectinib' in the name indicates that Zurletrectinib is a tropomyosin receptor kinase (TRK) inhibitor. Zurletrectinib has a monoisotopic molecular weight of 415.16 Da.

  2. Drug

    Rolusafine

    go.drugbank.com/drugs/DB21617
    Experimental

    The usage of the INN stem '-afine' in the name indicates that Rolusafine is a antifungal squalene mono-oxygenase inhibitor. Rolusafine has a monoisotopic molecular weight of 306.14 Da.

  3. Drug

    Merigolix

    go.drugbank.com/drugs/DB21628
    Experimental

    The usage of the INN stem '-golix' in the name indicates that Merigolix is a gonadotropin releasing hormone (GnRH) antagonist. Merigolix has a monoisotopic molecular weight of 752.24 Da.

  4. Drug

    Lerzeparib

    go.drugbank.com/drugs/DB21650
    Experimental

    The usage of the INN stem '-parib' in the name indicates that Lerzeparib is a poly-ADP-Ribose polymerase inhibitor. Lerzeparib has a monoisotopic molecular weight of 365.15 Da.

  5. Drug

    Nurandociguat

    go.drugbank.com/drugs/DB21720
    Investigational

    The usage of the INN stem '-ciguat' in the name indicates that Nurandociguat is a guanylate cyclase activator and stimulator. Nurandociguat has a monoisotopic molecular weight of 571.25 Da.

  6. Drug

    Adenosine 5'-phosphosulfate

    go.drugbank.com/drugs/DB03708
    Investigational

    The initial compound formed by the action of ATP sulfurylase on sulfate ions after sulfate uptake. Synonyms: adenosine sulfatophosphate; APS.

  7. Drug

    Reposal

    go.drugbank.com/drugs/DB13805
    Experimental

    Reposal is a barbiturate derivative invented in the 1960s in Denmark that has sedative, hypnotic and anticonvulsant properties. It was used primarily in the treatment of insomnia.

  8. Drug

    VaxSyn

    go.drugbank.com/drugs/DB17827
    Investigational

    VaxSyn HIV-1 is a recombinant form of the HIV envelope protein gp 160 developed by MicroGeneSys and the National Institute of Allergy and Infectious Diseases (NIAID).

    Synonyms: Human T-lymphotropic virus type III Gp160 antigens
  9. Drug

    Daglutril

    go.drugbank.com/drugs/DB05796
    Investigational

    Daglutril is an orally active, mixed neutral endopeptidase/endothelin converting enzyme inhibitor under development for the treatment of essential hypertension and congestive heart failure.

  10. Drug

    Desidustat

    go.drugbank.com/drugs/DB16135
    Investigational

    Desidustat is under investigation in clinical trial NCT04012957 (Desidustat in the Treatment of Anemia in CKD).